Abrilumab

AMG 181 · Amgen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Abrilumab, covering 2019-06-27 to 2019-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis [Phase 2]